Navigation Links
Unilife Launches New Corporate Website
Date:6/18/2013

y differentiated device platforms can be customized by Unilife to address specific customer, drug and patient requirements. Unilife's global headquarters and state-of-the-art manufacturing facilities are located in York, PA. For more information, please visit www.unilife.com or download the Unilife IRapp on your iPhone, iPad or Android device.

General: UNIS-G Investor Contacts (US):
Analyst Enquiries

Investor Contacts(Australia)

Media ContactTodd Fromer / Garth Russell

Lynn Pieper

Jeff Carter

Eve McGrathKCSA Strategic Communications

Westwicke Partners

Unilife Corporation

Rubenstein PRP: + 1 212-682-6300

P: + 1 415-202-5678

P: + 61 2 8346 6500

P: + 1 212 843-8490


'/>"/>
SOURCE Unilife Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Unilife to Present at the Jefferies 2013 Global Healthcare Conference in New York City on June 4th
2. Unilife Corporation Announces Financial Results For Fiscal Year 2013 Second Quarter
3. Unilife to Showcase Broad Portfolio of Innovative, Differentiated Injectable Drug Delivery Systems at Pharmapack Europe
4. Unilife Corporation To Announce Financial Results For Fiscal 2013 Second Quarter On Monday, February 11, 2013
5. Unilife to Present at the Lazard 9th Annual Healthcare Conference in New York City on November 13th
6. Unilife Corporation Announces Financial Results For Fiscal Year 2013 First Quarter
7. Unilifes Bolus Injector Platform Targeted by Global Pharmaceutical Company for Use in Multi-Drug Program
8. Unilife Corporation Reschedules Release Of Quarterly Results And Earnings Call Due To Severe Weather In Northeastern U.S.
9. Second Part of the Griffin Securities Analyst Interview with Unilife Corp. CEO is Now Available
10. Unilife Corporation To Announce Financial Results For Fiscal 2013 First Quarter On Tuesday, October 30, 2012
11. Griffin Securities Analyst Interviews Unilife Corp. CEO in a Two-Part Video Series
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... R.I. , Aug. 21, 2014 CVS Caremark ... tender results, applicable Reference Yields and consideration payable in connection ... commenced on August 7, 2014 for (1) any and all ... All Notes") and (2) up to a maximum amount of ... 2041 and 5.750% Senior Notes due 2017 (collectively, the "Maximum ...
(Date:8/21/2014)... , Aug. 21, 2014 Professional Compounding ... paediatric medicine by awarding the three best scientific ... initiative (EuPFI) conference . The Formulating Better ... 18 in Athens, Greece , ... students and professionals, from which three winners will ...
(Date:8/21/2014)... 2014   Royal Philips (NYSE: ... has received 510(k) clearance from the U.S. Food ... application for Transcatheter Aortic-Valve Implantation (TAVI) treatments. Through ... with pre-procedural, high-precision positioning to treat aortic stenosis ... is available as part of Philips IntelliSpace ...
Breaking Medicine Technology:CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 3CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 4CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 5CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 6Professional Compounding Centers of America will award top poster-session winners at European Paediatric Formulation Initiative in Athens 2Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 2Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 3
... Cell Therapeutics, Inc. ("CTI") (NASDAQ and MTA: ... of the peer reviewed journal, Leukemia & ... of a phase I/II clinical trial evaluating the ... in treating patients with aggressive non-Hodgkin,s lymphoma ("NHL") ...
... BASKING RIDGE, N.J., April 3, 2011 Regado Biosciences, ... antithrombotic aptamers with active control agents, announced today the ... of the company,s lead product, the anticoagulation system REG1, ... Cardiology 2011 60th Annual Scientific Session & Expo in ...
Cached Medicine Technology:Substitution of Pixantrone for Doxorubicin in CHOP Chemotherapy Regimen Produces High Rates of Complete Remissions and Long-Term Disease Free Survival in Patients with Relapsed/Refractory Aggressive NHL Who Previously Failed Frontline CHOP Therapy 2Substitution of Pixantrone for Doxorubicin in CHOP Chemotherapy Regimen Produces High Rates of Complete Remissions and Long-Term Disease Free Survival in Patients with Relapsed/Refractory Aggressive NHL Who Previously Failed Frontline CHOP Therapy 3Substitution of Pixantrone for Doxorubicin in CHOP Chemotherapy Regimen Produces High Rates of Complete Remissions and Long-Term Disease Free Survival in Patients with Relapsed/Refractory Aggressive NHL Who Previously Failed Frontline CHOP Therapy 4Substitution of Pixantrone for Doxorubicin in CHOP Chemotherapy Regimen Produces High Rates of Complete Remissions and Long-Term Disease Free Survival in Patients with Relapsed/Refractory Aggressive NHL Who Previously Failed Frontline CHOP Therapy 5Substitution of Pixantrone for Doxorubicin in CHOP Chemotherapy Regimen Produces High Rates of Complete Remissions and Long-Term Disease Free Survival in Patients with Relapsed/Refractory Aggressive NHL Who Previously Failed Frontline CHOP Therapy 6Regado Biosciences, Inc. Presents Results of the RADAR Phase 2b Clinical Trial of its REG1 Anticoagulation System 2Regado Biosciences, Inc. Presents Results of the RADAR Phase 2b Clinical Trial of its REG1 Anticoagulation System 3Regado Biosciences, Inc. Presents Results of the RADAR Phase 2b Clinical Trial of its REG1 Anticoagulation System 4Regado Biosciences, Inc. Presents Results of the RADAR Phase 2b Clinical Trial of its REG1 Anticoagulation System 5
(Date:8/21/2014)... to use a laser to measure people,s blood sugar, ... to a portable size, the technique could allow diabetics ... blood. , "We are working hard to turn engineering ... their daily lives," said Claire Gmachl, the Eugene Higgins ... "With this work we hope to improve the lives ...
(Date:8/21/2014)... a genetically engineered line of mice that is expected ... Alzheimer,s and other diseases. , The mice carry ... in response to different calcium levels. This will allow ... to be studied in a new way. , "This ... brain works," said Petr Tvrdik, Ph.D., a research ...
(Date:8/21/2014)... 21, 2014 Entries are now open ... only comprehensive national awards program totally dedicated to recognizing ... and executive leadership. The entry deadline is Oct. 17. ... Estate Insights™, the first and only national magazine entirely ... investment. , “We launched the HREI Insights Awards program ...
(Date:8/21/2014)... Aug. 21, 2014 (HealthDay News) -- Black Americans are ... racial groups battling the blood sugar disease, a new ... National Health and Nutrition Examination Survey, which evaluates about ... the highest rates of a condition known as diabetic ... blindness in people with diabetes. Diabetic macular edema ...
(Date:8/21/2014)... According to the new report “Waterborne Coatings ... PTFE, PVDF, PVDC, & Others), by Application (Architectural, ... & Others) - Global Forecast to 2019” published ... estimated to reach $77,838.71 Million by 2019. , ... spread through 225 Slides and in-depth TOC on ...
Breaking Medicine News(10 mins):Health News:Laser device may end pin pricks, improve quality of life for diabetics 2Health News:Laser device may end pin pricks, improve quality of life for diabetics 3Health News:Mouse model for epilepsy, Alzheimer's gives window into the working brain 2Health News:Entries Open for 2014 HREI Insights Awards™ 2Health News:Entries Open for 2014 HREI Insights Awards™ 3Health News:Entries Open for 2014 HREI Insights Awards™ 4Health News:Blacks May Face Higher Risk of Diabetes-Linked Vision Loss 2Health News:Waterborne Coatings Market worth $77,838.71 Million by 2019 – New Report by MarketsandMarkets 2Health News:Waterborne Coatings Market worth $77,838.71 Million by 2019 – New Report by MarketsandMarkets 3Health News:Waterborne Coatings Market worth $77,838.71 Million by 2019 – New Report by MarketsandMarkets 4
... Ohio State University Medical Center Implants Two Patients ... Clinical TrialSYDNEY, and TUSTIN, Calif., April 21 Sunshine ... on innovative heart assist technologies, announced today that The ... Ohio has successfully completed the first two implants of ...
... Aethlon Medical, Inc. (OTC Bulletin Board: AEMD), ... device to treat infectious disease, today announced ... to lead its investor relations outreach programs. ... first medical device that can selectively remove ...
... Extend National Diabetes Awareness Campaign in Six Additional CitiesBRIDGEWATER, ... star Ben Vereen will reprise his role as a ... Diabetes Awareness with sanofi-aventis U.S. to share his ... extend the national campaign he kicked off in September ...
... site to help raise awareness of deadliest form of ... of Skin Cancer Awareness Month and the increasing incidence ... Society for Dermatologic Surgery (ASDS) has created a free ... Facebook site. The kit and site were created to ...
... cord injuries much more common than thought , , TUESDAY, April ... million people, live with some form of paralysis, a new ... now, said Joseph Canose, vice president of quality of life ... survey Tuesday. The foundation was created by the late actor ...
... Money-Saving Options Now Available through Schiff(R) Loyalty RewardsSALT LAKE ... the most trusted and respected brands in the nutritional ... Schiff(R) Loyalty Rewards. The new incentive program offers ... Schiff(R) Glucosamine product purchased (at participating retailers). These ...
Cached Medicine News:Health News:First Patients in United States Receive Innovative Device to Treat Moderate Heart Failure 2Health News:First Patients in United States Receive Innovative Device to Treat Moderate Heart Failure 3Health News:First Patients in United States Receive Innovative Device to Treat Moderate Heart Failure 4Health News:Aethlon Medical Announces Engagement of RedChip Companies to Initiate Investor and Media Relations Programs 2Health News:Aethlon Medical Announces Engagement of RedChip Companies to Initiate Investor and Media Relations Programs 3Health News:Video: American Performing Icon Ben Vereen Encourages People to 'Take the Stage' and Act on Their Diabetes in 2009 2Health News:Video: American Performing Icon Ben Vereen Encourages People to 'Take the Stage' and Act on Their Diabetes in 2009 3Health News:Video: American Performing Icon Ben Vereen Encourages People to 'Take the Stage' and Act on Their Diabetes in 2009 4Health News:The ASDS Introduces the First At-Home Skin Cancer Exam Kit 2Health News:One in 50 Americans Lives With Paralysis 2Health News:One in 50 Americans Lives With Paralysis 3Health News:Schiff(R) Unveils Loyalty Program to Reward Valued Customers 2
Data review and analysis is carried out with the Acquidata Uromac software already supplied with Acquidata Uromac Lab based urodynamics systems...
... TT™ offers the ultimate research level wireless ... knowledgeable clinician and researcher today. Offering superb ... to meet your desired footprint requirements. Choose ... display live data both in the room ...
... diagnostic capabilities combined with ease of use ... in its class. Ideal for office or ... system for Uroflowmetry, cystometry, leak point pressure, ... are available which make the OM-5 flexible ...
... diagnostic capabilities combined with ease of use ... in its class. Ideal for office or ... system for Uroflowmetry, cystometry, leak point pressure, ... are available which make the OM-5 flexible ...
Medicine Products: